These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 781380

  • 1. Classical complement pathway activation in membranoproliferative glomerulonephritis.
    Ooi YM, Vallota EH, West CD.
    Kidney Int; 1976 Jan; 9(1):46-53. PubMed ID: 781380
    [Abstract] [Full Text] [Related]

  • 2. Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis.
    Schena FP, Pertosa G, Stanziale P, Vox E, Pecoraro C, Andreucci VE.
    Clin Nephrol; 1982 Nov; 18(5):240-6. PubMed ID: 7151338
    [Abstract] [Full Text] [Related]

  • 3. [Complement and nephritic activity in membranoproliferative glomerulonephritis].
    Lévy M, Sich M, Habib R.
    Arch Fr Pediatr; 1979 Nov; 36(9 Suppl):LXIV-LXXIV. PubMed ID: 539879
    [Abstract] [Full Text] [Related]

  • 4. Patterns of complement activation in idiopathic membranoproliferative glomerulonephritis, types I, II, and III.
    Varade WS, Forristal J, West CD.
    Am J Kidney Dis; 1990 Sep; 16(3):196-206. PubMed ID: 2205097
    [Abstract] [Full Text] [Related]

  • 5. Immunofluorescence patterns in chronic membranoproliferative glomerulonephritis (MPGN).
    Belgiojoso GB, Tarantino A, Bazzi C, Colasanti G, Guerra L, Durante A.
    Clin Nephrol; 1976 Jul; 6(1):303-10. PubMed ID: 782750
    [Abstract] [Full Text] [Related]

  • 6. Immunopathology of membranoproliferative glomerulonephritis with subendothelial deposits (Type I MPGN).
    Levy M, Gubler MC, Sich M, Beziau A, Habib R.
    Clin Immunol Immunopathol; 1978 Aug; 10(4):477-92. PubMed ID: 357058
    [No Abstract] [Full Text] [Related]

  • 7. Unraveling the Molecular Mechanisms Underlying Complement Dysregulation by Nephritic Factors in C3G and IC-MPGN.
    Donadelli R, Pulieri P, Piras R, Iatropoulos P, Valoti E, Benigni A, Remuzzi G, Noris M.
    Front Immunol; 2018 Aug; 9():2329. PubMed ID: 30487789
    [Abstract] [Full Text] [Related]

  • 8. Immunofluorescence studies of dense deposit disease. The presence of railroad tracks and mesangial rings.
    Kim Y, Vernier RL, Fish AJ, Michael AF.
    Lab Invest; 1979 Apr; 40(4):474-80. PubMed ID: 372673
    [Abstract] [Full Text] [Related]

  • 9. A properdin dependent nephritic factor slowly activating C3, C5, and C9 in membranoproliferative glomerulonephritis, types I and III.
    Clardy CW, Forristal J, Strife CF, West CD.
    Clin Immunol Immunopathol; 1989 Mar; 50(3):333-47. PubMed ID: 2917424
    [Abstract] [Full Text] [Related]

  • 10. [Partial lipodystrophy, hypocomplementemia and glomerulonephritis].
    Habib R, Lévy M, Gubler MC, Broyer M, Habib M.
    Arch Fr Pediatr; 1977 Mar; 34(7 Suppl):CXCVII-CCXII. PubMed ID: 931525
    [Abstract] [Full Text] [Related]

  • 11. Membranoproliferative glomerulonephritis with disruption of the glomerular basement membrane.
    Strife CF, McEnery PT, McAdams AJ, West CD.
    Clin Nephrol; 1977 Feb; 7(2):65-72. PubMed ID: 844227
    [Abstract] [Full Text] [Related]

  • 12. Discordant renal histopathologic findings and complement profiles in membranoproliferative glomerulonephritis type III.
    Meyers KE, Strife CF, Witzleben C, Kaplan BS.
    Am J Kidney Dis; 1996 Dec; 28(6):804-10. PubMed ID: 8957031
    [Abstract] [Full Text] [Related]

  • 13. Alternative C3 pathway activiation in pneumococcal glomerulonephritis.
    Hyman LR, Jenis EH, Hill GS, Zimmerman SW, Burkholder PM.
    Am J Med; 1975 Jun; 58(6):810-4. PubMed ID: 1094828
    [Abstract] [Full Text] [Related]

  • 14. Membranoproliferative glomerulonephritis. Localization of early components of complement in glomerular deposits.
    Davis BK, Cavallo T.
    Am J Pathol; 1976 Aug; 84(2):283-98. PubMed ID: 133617
    [Abstract] [Full Text] [Related]

  • 15. Measles and acute glomerulonephritis.
    Lin CY, Hsu HC.
    Pediatrics; 1983 Mar; 71(3):398-401. PubMed ID: 6219335
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Transitory deficiency of Clq and C4 in a case of chronic glomerulonephritis].
    Schena FP, Piscitelli M, Lucivero G, Marzullo F.
    Minerva Nefrol; 1975 Mar; 22(6):266-71. PubMed ID: 1223704
    [No Abstract] [Full Text] [Related]

  • 19. C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.
    Tanuma Y, Ohi H, Watanabe S, Seki M, Hatano M.
    Clin Exp Immunol; 1989 Apr; 76(1):82-5. PubMed ID: 2736802
    [Abstract] [Full Text] [Related]

  • 20. [Activation of the complement system in different forms of glomerulonephritis].
    Wegmüller E, Frey B, Hodler J.
    Schweiz Med Wochenschr; 1977 Jul 23; 107(29):1028-34. PubMed ID: 331469
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.